InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Call Matthew, 首席运营官. Director active across 2 companies, notably iTeos Therapeutics, Inc.. In total, 5 disclosures have been logged. Activity tracked since 30 July 2021. The latest transaction was filed on 7 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Call Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
161,898 股Common StockSEC:0000950170-25-112241:0
24,000 股0Common StockSEC:0000950170-25-037520:0
44,000 股0Common StockSEC:0000950170-23-068902:0
40,226 股@ US$2.9529.1% 占其流量Common StockSEC:0001209191-23-021566:0
53,672 股@ US$2.9554.9% 占其流量Common StockSEC:0001209191-21-050063:0
5 条申报中的 5 条
About Call Matthew
Matthew Call serves as Chief Operating Officer of iTeos Therapeutics, Inc. He oversees the company's daily operations and ensures the efficiency of internal processes. Matthew plays a key role in implementing the business strategy and optimizing resources to support iTeos' growth.
